Skip to main content
Fig. 3 | Stem Cell Research & Therapy

Fig. 3

From: Hypoxia preconditioned bone marrow-derived mesenchymal stromal/stem cells enhance myoblast fusion and skeletal muscle regeneration

Fig. 3

Expression of selected markers in cell cultures. A Level of transcripts encoding PAX7, MYF5, MYOD1, myogenin (MYOG), VCAM1, NCAM1, CD9, ADAM9, m-cadherin (CDH15) in mouse primary myoblasts (mPM) cultured in PMmed or MSCsmed under normoxic (NORM) or hypoxic (HYPO) conditions. B Level of transcripts encoding MYF5, MYOD1, myogenin (MYOG), VCAM1, CD9, ADAM9, m-cadherin (CDH15), nestin (NES) in human bone marrow-derived mesenchymal stromal cells (hMSC) cultured in PMmed or MSCsmed under normoxic (NORM) or hypoxic (HYPO) conditions. C Level of transcripts encoding myogenin (MYOG), α-sarcoglycan (SGCA), desmin (DES), and actin α1 (ACTA1) in pig bone marrow-derived mesenchymal stem cells (pMSC) cultured in PMmed or MSCsmed under normoxic (NORM) or hypoxic (HYPO) conditions. P value: *< 0.05; **< 0.01; ***< 0.001; ****< 0.0001

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512